Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel diseaseI. Ahmed, C Probert, Rosemary Greenwood et al.|Alimentary Pharmacology & Therapeutics|2016Cited by 143
HMB‐45 staining of dysplastic melanocytic nevi in melanoma risk groupsI. Ahmed, John J. Zone, Lisa Cannon‐Albright et al.|Journal of Cutaneous Pathology|1991Cited by 15
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ replyI. Ahmed, C Probert, Norman Ratcliffe et al.|Alimentary Pharmacology & Therapeutics|2016Cited by 2